Title:
TREATMENT OF HERPES SIMPLEX VIRUS INFECTION
Document Type and Number:
WIPO Patent Application WO/2024/046476
Kind Code:
A1
Abstract:
The present invention relates to the treatment of herpes simplex virus (HSV) infection using an anti-HSV antibody. In particular, the anti-HSV antibody specifically binds to the glycoprotein D (gD) of herpes simplex virus-1 (HSV-1) and herpes simplex virus-2 (HSV-2). The treatment of the present invention is effective against drug-resistant and/or recurrent HSV infection.
Inventors:
KUO BE-SHENG (CN)
LI CHAO-HUNG (CN)
SHAO HSIAO-YUN (CN)
LIU YAW-JEN (CN)
LYNN SHUGENE (CN)
WANG CHANG YI (CN)
LI CHAO-HUNG (CN)
SHAO HSIAO-YUN (CN)
LIU YAW-JEN (CN)
LYNN SHUGENE (CN)
WANG CHANG YI (CN)
Application Number:
PCT/CN2023/116576
Publication Date:
March 07, 2024
Filing Date:
September 01, 2023
Export Citation:
Assignee:
UNITED BIOPHARMA INC (CN)
International Classes:
A61K39/42; A61K39/395; A61P31/22; C07K16/08; G01N33/563; G01N33/569
Foreign References:
| US20140302062A1 | 2014-10-09 | |||
| US20100172906A1 | 2010-07-08 | |||
| CN106488931A | 2017-03-08 | |||
| US5679348A | 1997-10-21 | |||
| US6156313A | 2000-12-05 |
Attorney, Agent or Firm:
GE CHENG & CO., LTD (CN)
Download PDF: